Clinical Trial

Diagnostic Creteria of Acid Sphingomyelinase Deficiency (ASMD)

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 10, 2025 (before its estimated August 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
Acid sphingomyelinase Deficiency known as Neiman \_PICK disease is a group of rare genetic diseases. This study includes analysis of clinical manifestations in patients with ASMD and investigations done for diagnosis of these patients
Trial Details
NCT Number NCT07274826
Lead Sponsor Sohag University
Conditions Acid Sphingomyelinase Deficiency (ASMD)
Enrollment 7 participants
Start Date 2025-11-20
Primary Completion 2026-08-10 (estimated)
Study Completion 2026-09-10 (estimated)
Updated on ClinicalTrials.gov 2025-12-10